Essential Thrombocythemia (ET)
- Is a rare blood disease in which the bone marrow produces too many platelets. High numbers of platelets may lead to a thrombus, a blood clot that forms in a blood vessel. This can cause serious health problems such as a stroke, heart attack or pulmonary embolism
- Is one of a related group of blood cancers known as “myeloproliferative neoplasms” (MPNs) in which cells in the bone marrow that produce the blood cells develop and function abnormally.
- On average, individuals with ET have a normal life expectancy if they are properly monitored and treated. In a small number of patients, the disease may transform to myelofibrosis, acute myeloid leukemia or, less frequently, myelodysplastic syndrome.
What You Should Know
- Hematologists oncologists are specialists who treat people who have ET or other types of blood cancer.
- ET does not generally shorten life expectancy. However, medical supervision is important to prevent or treat thrombosis, a serious complication that can affect vital organs such as the brain or the heart. Also, for untreated pregnant patients with ET, there is a risk to the survival of the fetus.
What You Should Do
- Talk with your doctor about your diagnostic tests and what the results mean
- Talk with your doctor about all your treatment options, side effects, and the results you can expect from treatment.
- Ask your doctor whether a clinical trial is a good treatment option for you.
How Does ET Develop?
The DNA (genetic material) of a developing stem cell in the bone marrow is damaged.
Stem cells form blood cells (white cells, red cells and platelets).
The mutated cell leads to uncontrolled blood cell production, especially platelets - although red cells and white cells are usually affected as well.
- There is mainly an overproduction of platelet-forming cells, called "megakaryocytes," in the marrow.
This results in the release of too many platelets into the blood.
- The platelets’ function is to start the process of forming a plug (clot) in response to blood vessel injury in order to prevent or minimize bleeding. When platelets are present in very high numbers they may not function normally and may cause a blockage in blood vessels, known as a "thrombus." Less often, a high number of platelets can also cause bleeding problems.
Another word for platelet is "thrombocyte." The term "thrombocythemia" means an excess of platelets in the blood. The term "essential" indicates that the increase in platelets is an innate problem of the blood cell production in the bone marrow. "Secondary thrombocytosis" is the term for a condition that results in very high platelet counts in the blood in reaction to another problem in the patient's body, such as inflammatory disease, removal of the spleen, or iron deficiency in adults. A patient with secondary, or reactive, thrombocytosis should have a return to normal platelet count in the blood once the primary problem is treated successfully.
Source: Myeloproliferative Neoplasms. Reviewed by John Mascarenhas, MD.
Please consider a donation to LLS so we can continue to provide patient support and education and fund research to improve outcomes for all blood cancer patients.